• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发热性中性粒细胞减少症患者不良预后的预测因素

Independent factors for prediction of poor outcomes in patients with febrile neutropenia.

作者信息

Günalp Müge, Koyunoğlu Merve, Gürler Serdar, Koca Ayça, Yeşilkaya Ilker, Öner Emre, Akkaş Meltem, Metin Aksu Nalan, Demirkan Arda, Polat Onur, Elhan Atilla Halil

机构信息

Department of Emergency Medicine, Ankara University School of Medicine, Ankara, Turkey.

Department of Emergency Medicine, Hacettepe University School of Medicine, Ankara, Turkey.

出版信息

Med Sci Monit. 2014 Oct 5;20:1826-32. doi: 10.12659/MSM.892269.

DOI:10.12659/MSM.892269
PMID:25282155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4199395/
Abstract

BACKGROUND

Febrile neutropenia (FN) is a life-threatening condition that requires urgent management in the emergency department (ED). Recent progress in the treatment of neutropenic fever has underscored the importance of risk stratification. In this study, we aimed to determine independent factors for prediction of poor outcomes in patients with FN.

MATERIAL AND METHODS

We retrospectively evaluated 200 chemotherapy-induced febrile neutropenic patients who visited the ED. Upon arrival at the ED, clinical data, including sex, age, vital signs, underlying systemic diseases, laboratory test results, estimated GFR, blood cultures, CRP, radiologic examinations, and Multinational Association of Supportive Care in Cancer (MASCC) score of all febrile neutropenic patients were obtained. Outcomes were categorized as "poor" if serious complications during hospitalization, including death, occurred.

RESULTS

The platelet count <50 000 cells/mm3 (OR 3.90, 95% CI 1.62-9.43), pulmonary infiltration (OR 3.45, 95% CI 1.48-8.07), hypoproteinemia <6 g/dl (OR 3.30, 95% CI 1.27-8.56), respiratory rate >24/min (OR 8.75, 95% CI 2.18-35.13), and MASCC score <21 (OR 9.20, 95% CI 3.98-21.26) were determined as independent risk factors for the prediction of death. The platelet count <50 000 cells/mm3 (OR 3.93, 95% CI 1.42-10.92), serum CRP >50 mg/dl (OR 3.80, 95% CI 1.68-8.61), hypoproteinemia (OR 7.81, 95% CI 3.43-17.78), eGFR ≤90 ML/min/1.73 m2 (OR 3.06, 95% CI 1.13-8.26), and MASCC score <21 (OR 3.45, 95% CI 1.53-7.79) were determined as independent risk factors for the prediction of poor clinical outcomes of FN patients. Platelet count, protein level, respiratory rate, pulmonary infiltration, CRP, MASCC score, and eGFR were shown to have a significant association with outcome.

CONCLUSIONS

The results of our study may help emergency medicine physicians to prevent serious complications with proper use of simple independent risk factors besides MASCC score.

摘要

背景

发热性中性粒细胞减少症(FN)是一种危及生命的疾病,需要在急诊科(ED)进行紧急处理。中性粒细胞减少性发热治疗的最新进展凸显了风险分层的重要性。在本研究中,我们旨在确定预测FN患者不良结局的独立因素。

材料与方法

我们回顾性评估了200名因化疗导致发热性中性粒细胞减少并前往急诊科就诊的患者。所有发热性中性粒细胞减少症患者到达急诊科时,获取其临床数据,包括性别、年龄、生命体征、潜在的全身性疾病、实验室检查结果、估计的肾小球滤过率、血培养、C反应蛋白(CRP)、影像学检查以及多国支持性癌症护理协会(MASCC)评分。如果住院期间发生包括死亡在内的严重并发症,则将结局分类为“不良”。

结果

血小板计数<50000个/立方毫米(比值比[OR]3.90,95%置信区间[CI]1.62 - 9.43)、肺部浸润(OR 3.45,95% CI 1.48 - 8.07)、低蛋白血症<6 g/dl(OR 3.30,95% CI 1.27 - 8.56)、呼吸频率>24次/分钟(OR 8.75,95% CI 2.18 - 35.13)以及MASCC评分<21(OR 9.20,95% CI 3.98 - 21.26)被确定为预测死亡的独立危险因素。血小板计数<50000个/立方毫米(OR 3.93,95% CI 1.42 - 10.92)、血清CRP>50 mg/dl(OR 3.80,95% CI 1.68 - 8.61)、低蛋白血症(OR 7.81,95% CI 3.43 - 17.78)、估算肾小球滤过率(eGFR)≤90 ml/min/1.73平方米(OR 3.06,95% CI 1.13 - 8.26)以及MASCC评分<21(OR 3.45,95% CI 1.53 - 7.79)被确定为预测FN患者不良临床结局的独立危险因素。血小板计数、蛋白水平、呼吸频率、肺部浸润、CRP、MASCC评分和eGFR均显示与结局有显著关联。

结论

我们的研究结果可能有助于急诊医学医生除了使用MASCC评分外,通过合理运用简单的独立危险因素来预防严重并发症。

相似文献

1
Independent factors for prediction of poor outcomes in patients with febrile neutropenia.发热性中性粒细胞减少症患者不良预后的预测因素
Med Sci Monit. 2014 Oct 5;20:1826-32. doi: 10.12659/MSM.892269.
2
Adding procalcitonin to the MASCC risk-index score could improve risk stratification of patients with febrile neutropenia.添加降钙素原到 MASCC 风险指数评分中可能有助于改善发热性中性粒细胞减少症患者的风险分层。
Support Care Cancer. 2013 Aug;21(8):2303-8. doi: 10.1007/s00520-013-1787-6. Epub 2013 Mar 22.
3
Application of the MASCC and CISNE Risk-Stratification Scores to Identify Low-Risk Febrile Neutropenic Patients in the Emergency Department.应用MASCC和CISNE风险分层评分识别急诊科低风险发热性中性粒细胞减少患者。
Ann Emerg Med. 2017 Jun;69(6):755-764. doi: 10.1016/j.annemergmed.2016.11.007. Epub 2016 Dec 29.
4
Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers in three continents.MASCC 和 CISNE 评分用于识别低危中性粒细胞减少性发热患者的比较:来自三大洲三个癌症中心急诊部的数据分析。
Support Care Cancer. 2018 May;26(5):1465-1470. doi: 10.1007/s00520-017-3985-0. Epub 2017 Nov 22.
5
Usefulness of complete blood count parameters to predict poor outcomes in cancer patients with febrile neutropenia presenting to the emergency department.全血细胞计数参数在预测因发热性中性粒细胞减少症而就诊于急诊科的癌症患者不良结局中的作用。
Ann Med. 2022 Dec;54(1):599-609. doi: 10.1080/07853890.2022.2031271.
6
Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia.癌症患者化疗引起的发热性中性粒细胞减少症预后不良的预测因素。
Support Care Cancer. 2011 Aug;19(8):1151-8. doi: 10.1007/s00520-010-0928-4. Epub 2010 Jun 16.
7
Emergency department management of chemotherapy related febrile neutropenia: An opportunity to improve care.急诊科对化疗相关性发热性中性粒细胞减少症的管理:改善护理的机会。
Am J Emerg Med. 2021 Dec;50:5-9. doi: 10.1016/j.ajem.2021.07.008. Epub 2021 Jul 9.
8
C-reactive protein and the MASCC risk index identify high-risk patients with febrile neutropenia and hematologic neoplasms.C反应蛋白和MASCC风险指数可识别发热性中性粒细胞减少症和血液系统肿瘤的高危患者。
Support Care Cancer. 2015 Apr;23(4):1009-13. doi: 10.1007/s00520-014-2454-2. Epub 2014 Oct 2.
9
Can Risk Stratification Tools Be Utilized to Safely Discharge Low-Risk Febrile Neutropenic Patients from the Emergency Department?风险分层工具能否用于安全地让低风险发热性中性粒细胞减少患者从急诊科出院?
J Emerg Med. 2023 Jan;64(1):111-118. doi: 10.1016/j.jemermed.2022.10.010. Epub 2023 Jan 12.
10
Use of MASCC score in the inpatient management of febrile neutropenia: a single-center retrospective study.MASCC 评分在发热性中性粒细胞减少症住院管理中的应用:一项单中心回顾性研究。
Support Care Cancer. 2021 Oct;29(10):5905-5914. doi: 10.1007/s00520-021-06154-4. Epub 2021 Mar 24.

引用本文的文献

1
Clinical Outcome of Febrile Neutropenia and Associated Factors Among Adult Patients with Cancer Treated at Ethiopian Oncology Centers: A Retrospective Observational Study.埃塞俄比亚肿瘤中心接受治疗的成年癌症患者发热性中性粒细胞减少症的临床结局及相关因素:一项回顾性观察研究
Oncol Ther. 2025 Jul 16. doi: 10.1007/s40487-025-00356-0.
2
Factors influencing hospital length of stay in febrile neutropenia: A retrospective cohort study of Turkish patients with solid tumors.影响发热性中性粒细胞减少症患者住院时间的因素:对土耳其实体瘤患者的一项回顾性队列研究
Medicine (Baltimore). 2025 Jul 4;104(27):e43105. doi: 10.1097/MD.0000000000043105.
3
Clinical profile, treatment, and outcomes of febrile neutropenia in hematologic disorders: a look at 30-day mortality predictors.血液系统疾病中发热性中性粒细胞减少症的临床特征、治疗及预后:30天死亡率预测因素分析
Sci Rep. 2025 Jul 4;15(1):23905. doi: 10.1038/s41598-025-06787-z.
4
Clinical prediction models for febrile neutropenia and its outcomes: a systematic review.发热性中性粒细胞减少症及其预后的临床预测模型:一项系统评价
Support Care Cancer. 2025 Jun 4;33(7):537. doi: 10.1007/s00520-025-09562-y.
5
PCT-to-albumin ratio and CRP-to-albumin ratio as predictors of febrile neutropenia complications: a prospective observational trial.降钙素原与白蛋白比值及C反应蛋白与白蛋白比值作为发热性中性粒细胞减少症并发症预测指标的前瞻性观察性试验
Support Care Cancer. 2025 Mar 10;33(4):262. doi: 10.1007/s00520-025-09329-5.
6
Can MASCC and CISNE scores predict delays of lung cancer chemotherapy after febrile neutropenia?MASCC 和 CISNE 评分能否预测发热性中性粒细胞减少后肺癌化疗的延迟?
Thorac Cancer. 2022 Dec;13(24):3504-3509. doi: 10.1111/1759-7714.14720. Epub 2022 Nov 4.
7
Clinical factors predictive of mortality in acute leukemia patients with febrile neutropenia.急性白血病发热性中性粒细胞减少症患者死亡率的临床预测因素。
Am J Blood Res. 2021 Feb 15;11(1):59-65. eCollection 2021.
8
Use of MASCC score in the inpatient management of febrile neutropenia: a single-center retrospective study.MASCC 评分在发热性中性粒细胞减少症住院管理中的应用:一项单中心回顾性研究。
Support Care Cancer. 2021 Oct;29(10):5905-5914. doi: 10.1007/s00520-021-06154-4. Epub 2021 Mar 24.
9
Current management of chemotherapy-induced neutropenia in adults: key points and new challenges: Committee of Neoplastic Supportive-Care (CONS), China Anti-Cancer Association Committee of Clinical Chemotherapy, China Anti-Cancer Association.成人化疗所致中性粒细胞减少症的当前管理:要点和新挑战:中国抗癌协会肿瘤支持治疗专业委员会、中国抗癌协会临床化疗专业委员会。
Cancer Biol Med. 2020 Nov 15;17(4):896-909. doi: 10.20892/j.issn.2095-3941.2020.0069. Epub 2020 Dec 15.
10
Predicting in-hospital mortality of patients with febrile neutropenia using machine learning models.使用机器学习模型预测发热性中性粒细胞减少症患者的住院死亡率。
Int J Med Inform. 2020 Jul;139:104140. doi: 10.1016/j.ijmedinf.2020.104140. Epub 2020 Apr 15.

本文引用的文献

1
Platelet mitochondrial membrane depolarization reflects disease severity in patients with sepsis and correlates with clinical outcome.血小板线粒体膜去极化反映脓毒症患者的疾病严重程度,并与临床结局相关。
Crit Care. 2014 Feb 12;18(1):R31. doi: 10.1186/cc13724.
2
European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia.欧洲发热性中性粒细胞减少患者抗菌经验性治疗指南:2011 年第 4 届欧洲白血病感染会议总结。
Haematologica. 2013 Dec;98(12):1826-35. doi: 10.3324/haematol.2013.091025.
3
Reduced estimated GFR and cancer mortality.估算肾小球滤过率降低与癌症死亡率。
Am J Kidney Dis. 2014 Jan;63(1):23-30. doi: 10.1053/j.ajkd.2013.07.008. Epub 2013 Aug 30.
4
Can we safely discharge low-risk patients with febrile neutropenia from the emergency department?我们能否安全地让急诊科的低风险发热性中性粒细胞减少症患者出院?
Ann Emerg Med. 2014 Jan;63(1):48-51. doi: 10.1016/j.annemergmed.2013.07.006. Epub 2013 Jul 19.
5
Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.恶性肿瘤成人患者发热与中性粒细胞减少的抗菌预防和门诊管理:美国临床肿瘤学会临床实践指南。
J Clin Oncol. 2013 Feb 20;31(6):794-810. doi: 10.1200/JCO.2012.45.8661. Epub 2013 Jan 14.
6
Risk factors associated with complications in patients with chemotherapy-induced febrile neutropenia in emergency department.与急诊化疗引起的发热性中性粒细胞减少症患者并发症相关的风险因素。
Hematol Oncol. 2013 Dec;31(4):189-96. doi: 10.1002/hon.2040. Epub 2013 Jan 9.
7
Predictive factors for poor prognosis febrile neutropenia.发热性中性粒细胞减少症预后不良的预测因素。
Curr Opin Oncol. 2012 Jul;24(4):376-80. doi: 10.1097/CCO.0b013e328352ead2.
8
Knowledge, beliefs and attitudes of kidney transplant recipients regarding their risk of cancer.肾移植受者对癌症风险的知识、信念和态度。
Nephrology (Carlton). 2012 Mar;17(3):300-6. doi: 10.1111/j.1440-1797.2011.01549.x.
9
Role of nutritional status in predicting the length of stay in cancer: a systematic review of the epidemiological literature.营养状况在预测癌症患者住院时间中的作用:系统综述流行病学文献。
Ann Nutr Metab. 2011;59(2-4):96-106. doi: 10.1159/000332914. Epub 2011 Dec 2.
10
Thrombocytopenia in Staphylococcus aureus bacteremia: risk factors and prognostic importance.金黄色葡萄球菌菌血症伴血小板减少症:危险因素和预后意义。
Mayo Clin Proc. 2011 May;86(5):389-96. doi: 10.4065/mcp.2010.0705.